Invitrogen™ CML66 Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA530857

Catalog No. PIPA530857

Description

Recommended positive controls: A549, HeLa, HepG2, HCT116. Predicted reactivity: Mouse (88%), Rat (88%), Bovine (92%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.

CML66, also known as TSGA10 (Testis Specific Gene A10), is a gene located on chromosome 8q23 that encodes a broadly immunogenic tumor antigen. The gene is expressed in various leukemias and solid tumors but has restricted expression in normal tissues, being predominantly found in the testis and heart. The physiological function of CML66 remains unclear. However, its immunogenic properties, including the ability to elicit strong humoral immune responses, make it a potential target for cancer immunotherapy. Studies have identified cytotoxic T lymphocyte (CTL) epitopes derived from CML66, suggesting that TSGA10-targeted therapies could be feasible. Moreover, research into the gene has revealed the existence of different isoforms, such as CML66-L (long) and CML66-S (short), which may have distinct roles in tumorigenesis and immune response modulation.

Specifications

• Antigen: CML66
• Classification: Polyclonal
• Conjugate: Unconjugated
• Gene: NUDCD1
• Gene Alias: 4921532K09Rik; AA407246; AW260430; AW556235; chronic myelogenous leukemia tumor antigen 66; CML66; CML66-L; NudC domain containing 1; nudC domain-containing protein 1; Nudcd1; OVA66; RGD1310624; Tumor antigen CML66
• Host Species: Rabbit
• Purification Method: Antigen affinity chromatography
• Regulatory Status: RUO
• Gene ID (Entrez): 84955
• Content And Storage: Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
• Form: Liquid

• Applications: Western Blot
• Concentration: 1 mg/mL
• Formulation: PBS with 1% BSA, 20% glycerol and 0.01% thimerosal; pH 7
• Gene Accession No.: Q96RS6
• Gene Symbols: NUDCD1
• Immunogen: Recombinant protein encompassing a sequence within the center region of human CML66. The exact sequence is proprietary.
• Quantity: 100 μL
• Primary or Secondary: Primary
• Target Species: Human
• Product Type: Antibody
• Isotype: IgG

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov